CHAD CREIGHTON to Genomics
This is a "connection" page, showing publications CHAD CREIGHTON has written about Genomics.
Connection Strength
2.972
-
The clinical applications of The Cancer Genome Atlas project for bladder cancer. Expert Rev Anticancer Ther. 2018 10; 18(10):973-980.
Score: 0.325
-
Genomic classifications of renal cell carcinoma: a critical step towards the future application of personalized kidney cancer care with pan-omics precision. J Pathol. 2018 04; 244(5):525-537.
Score: 0.314
-
Making Use of Cancer Genomic Databases. Curr Protoc Mol Biol. 2018 01 16; 121:19.14.1-19.14.13.
Score: 0.313
-
Multilevel Genomics-Based Taxonomy of Renal Cell Carcinoma. Cell Rep. 2016 Mar 15; 14(10):2476-89.
Score: 0.275
-
Integrated genomic analyses of ovarian carcinoma. Nature. 2011 Jun 29; 474(7353):609-15.
Score: 0.198
-
Inaugural Genomics Automation Congress and the coming deluge of sequencing data. Expert Rev Mol Diagn. 2010 Oct; 10(7):849-51.
Score: 0.189
-
An Overview of Analytical Approaches to Cancer Proteogenomics. Methods Mol Biol. 2025; 2921:93-118.
Score: 0.127
-
Using cancer proteomics data to identify gene candidates for therapeutic targeting. Oncotarget. 2023 05 04; 14:399-412.
Score: 0.113
-
Rearrangement-mediated cis-regulatory alterations in advanced patient tumors reveal interactions with therapy. Cell Rep. 2021 11 16; 37(7):110023.
Score: 0.102
-
SVExpress: identifying gene features altered recurrently in expression with nearby structural variant breakpoints. BMC Bioinformatics. 2021 Mar 21; 22(1):135.
Score: 0.097
-
A pediatric brain tumor atlas of genes deregulated by somatic genomic rearrangement. Nat Commun. 2021 02 10; 12(1):937.
Score: 0.097
-
Portals for Exploring Noncoding Variants in Pediatric Cancer. Trends Genet. 2021 04; 37(4):297-298.
Score: 0.096
-
Pan-Cancer Molecular Classes Transcending Tumor Lineage Across 32 Cancer Types, Multiple Data Platforms, and over 10,000 Cases. Clin Cancer Res. 2018 05 01; 24(9):2182-2193.
Score: 0.079
-
Pan-urologic cancer genomic subtypes that transcend tissue of origin. Nat Commun. 2017 08 04; 8(1):199.
Score: 0.076
-
Pan-cancer survey of epithelial-mesenchymal transition markers across the Cancer Genome Atlas. Dev Dyn. 2018 03; 247(3):555-564.
Score: 0.074
-
Multiplatform-based molecular subtypes of non-small-cell lung cancer. Oncogene. 2017 03; 36(10):1384-1393.
Score: 0.072
-
International cancer seminars: a focus on kidney cancer. Ann Oncol. 2016 08; 27(8):1382-5.
Score: 0.069
-
Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature. 2013 Jul 04; 499(7456):43-9.
Score: 0.057
-
Comprehensive molecular portraits of human breast tumours. Nature. 2012 Oct 04; 490(7418):61-70.
Score: 0.054
-
Comprehensive genomic characterization of squamous cell lung cancers. Nature. 2012 Sep 27; 489(7417):519-25.
Score: 0.054
-
Integrative genomics analysis reveals silencing of beta-adrenergic signaling by polycomb in prostate cancer. Cancer Cell. 2007 Nov; 12(5):419-31.
Score: 0.039
-
A functional genomic approach to actionable gene fusions for precision oncology. Sci Adv. 2022 02 11; 8(6):eabm2382.
Score: 0.026
-
UALCAN: An update to the integrated cancer data analysis platform. Neoplasia. 2022 03; 25:18-27.
Score: 0.026
-
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma. Cancer Cell. 2020 05 11; 37(5):720-734.e13.
Score: 0.023
-
Genomic basis for RNA alterations in cancer. Nature. 2020 02; 578(7793):129-136.
Score: 0.023
-
IL17A Regulates Tumor Latency and Metastasis in Lung Adeno and Squamous SQ.2b and AD.1 Cancer. Cancer Immunol Res. 2018 06; 6(6):645-657.
Score: 0.020
-
Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas. Cell Rep. 2018 04 03; 23(1):194-212.e6.
Score: 0.020
-
Invasive Bladder Cancer: Genomic Insights and Therapeutic Promise. Clin Cancer Res. 2015 Oct 15; 21(20):4514-24.
Score: 0.017